Todd Golub
 

The idea that you could take a piece of a patient's tumor, sequence it, and use that knowledge to guide treatment used to sound like science fiction. Today, says Broad chief scientific officer and Cancer Program director Todd Golub, that idea is starting to become reality. Golub will trace the science of cancer precision medicine, how it's evolved over the last 15 years, and where that path could take us.